title: Effects of AY9944 A-7 on gonadotropin-induced meiotic resumption of oocytes and development of parthenogenetic embryos in sheep.
abstract: Follicular fluid meiosis-activating sterol (FF-MAS), an intermediate in the cholesterol biosynthetic pathway, has been identified as a compound that induces the resumption of meiosis in mammalian oocyte. Follicular fluid meiosis-activating sterol is converted to testis meiosis-activating sterol by a sterol Δ14-reductase. An inhibitor of Δ14-reductase and Δ7-reductase, AY9944 A-7, causes accumulation of FF-MAS by inhibiting its metabolism. The objective of this research was to investigate the specific contribution of AY9944 A-7 on gonadotropin-induced meiotic resumption and its interactive effects with FSH or LH on meiotic maturation of oocytes and preimplantation development of parthenogenetic embryo in sheep by addition of AY9944 A-7 during IVM to cause accumulation of FF-MAS. First, ovine cumulus-oocyte complexes (COCs) were cultured in the presence of FSH (10 μg/mL), LH (10 μg/mL), AY9944 A-7 (20 μmol/L), FSH (10 μg/mL)+AY9944 A-7 (20 μmol/L), or LH (10 μg/ml) + AY9944 A-7 (20 μmol/L) with an inhibitor hypoxanthine (Hx) to prevent spontaneous meiosis of oocytes. The resumption of meiosis was assessed by the frequency of germinal vesicle breakdown and the first polar body (PBI) extrusion. The kinetics of gonadotropin and AY9944 A-7-induced meiotic resumption in vitro was also evaluated in the study. The numbers of oocytes resuming meiosis and undergoing germinal vesicle breakdown were counted after the COCs were cultured for 2, 4, 8, 12, 16, 20, and 24 hours. Matured oocytes extruding PBI were selected for parthenogenetic activation, and the percentages developing to the two-cell stage and blastocyst stage were recorded as indicators of parthenogenetic embryo developmental competence. It was observed that FSH could induce the resumption of meiosis of ovine COCs cultured in the presence of Hx, but LH could not. AY9944 A-7 had a synergistic effect with FSH on nuclear maturation and developmental competence of embryos produced by parthenogenetic activation, whereas it had no added advantage on LH action. However, the kinetics of meiotic resumption after AY9944 A-7 stimulation was remarkably delayed when compared with FSH-induced maturation. In conclusion, the current study suggested that AY9944 A-7 supplementation in IVM medium optimized the beneficial effects of FSH on meiotic maturation of ovine oocytes and subsequent developmental competence of embryos produced by parthenogenetic activation. This work had important potential for developing a novel technique in IVM of ovine oocytes.
authors.affiliation: College of Animal Science and Technology, Shanxi Agricultural University, Taigu, PR China; Lab of Animal Reproduction, Shanxi Agricultural University, Taigu, PR China. Electronic address: hrr823229@163.com.
authors.forename: Ruirong
authors.initials: R
authors.lastname: Hao
authors.affiliation: College of Animal Science and Technology, Shanxi Agricultural University, Taigu, PR China.
authors.forename: Chunxiang
authors.initials: C
authors.lastname: Zhang
authors.affiliation: College of Animal Science and Technology, Shanxi Agricultural University, Taigu, PR China; Lab of Animal Reproduction, Shanxi Agricultural University, Taigu, PR China.
authors.forename: Lihua
authors.initials: L
authors.lastname: Lv
authors.affiliation: College of Animal Science and Technology, Shanxi Agricultural University, Taigu, PR China; Lab of Animal Reproduction, Shanxi Agricultural University, Taigu, PR China.
authors.forename: Lei
authors.initials: L
authors.lastname: Shi
authors.affiliation: College of Animal Science and Technology, Shanxi Agricultural University, Taigu, PR China.
authors.forename: Wenbin
authors.initials: W
authors.lastname: Yue
mesh_terms: D000818:Animals; D004347:Drug Interactions; D046149:Embryo Culture Techniques / Q000662:veterinary; D047108:Embryonic Development / Q000187:drug effects*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000493:pharmacokinetics / Q000494:pharmacology; D006062:Gonadotropins / Q000494:pharmacology*; D059471:In Vitro Oocyte Maturation Techniques / Q000379:methods / Q000662:veterinary; D007986:Luteinizing Hormone / Q000493:pharmacokinetics / Q000494:pharmacology; D008540:Meiosis / Q000187:drug effects* / Q000502:physiology; D009865:Oocytes / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D010312:Parthenogenesis / Q000502:physiology*; D012756:Sheep / Q000196:embryology*; D013997:Time Factors; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride / Q000494:pharmacology*
chemical_list: D006062:Gonadotropins; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D010088:Oxidoreductases
keywords: AY9944 A-7; FF-MAS; FSH; Meiosis; Parthenogenetic embryo development